ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $255,000 | -6.2% | 1,145 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $272,000 | +1.9% | 1,145 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $267,000 | +13.1% | 1,145 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $236,000 | -11.9% | 1,145 | -12.3% | 0.00% | 0.0% |
| Q1 2021 | $268,000 | +8.9% | 1,305 | +14.0% | 0.00% | 0.0% |
| Q4 2020 | $246,000 | +17.7% | 1,145 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $209,000 | -88.9% | 1,145 | -84.7% | 0.00% | -90.0% |
| Q2 2019 | $1,885,000 | -72.3% | 7,481 | -73.7% | 0.01% | -73.7% |
| Q1 2019 | $6,801,000 | -12.8% | 28,415 | -16.3% | 0.04% | -20.8% |
| Q4 2018 | $7,800,000 | -15.6% | 33,967 | +3.9% | 0.05% | 0.0% |
| Q3 2018 | $9,241,000 | +187.4% | 32,682 | +198.5% | 0.05% | +166.7% |
| Q2 2018 | $3,215,000 | +895.4% | 10,947 | +529.1% | 0.02% | +800.0% |
| Q3 2017 | $323,000 | -68.6% | 1,740 | -70.9% | 0.00% | -66.7% |
| Q2 2017 | $1,030,000 | – | 5,970 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |